Ignite Creation Date:
2024-05-06 @ 5:52 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05462951
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2022-07-08
Brief Title:
Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Sponsor:
Denise Fabian
Organization:
University of Kentucky
Study Overview
Official Title:
Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer Women receive standard-of-care radiochemotherapy followed by brachytherapy Blood samples are obtained to detect circulating levels of deoxyribonucleotides human papillomavirus DNA and circulating tumor cells
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None